Pancreatic cancer is characterized by near-universal mutations in KRAS and frequent deregulation of crucial embryonic signaling pathways, such as the Hedgehog and Wnt-β-catenin pathways. This evidence concerns the gene KRAS and familial pancreatic carcinoma.